Viewing Study NCT06046534


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-28 @ 1:27 AM
Study NCT ID: NCT06046534
Status: COMPLETED
Last Update Posted: 2025-05-13
First Post: 2023-06-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module